Publication not explained
Read the Original
This page is a summary of: PMH27 COST-EFFECTIVENESS OF DULOXETINE VS. VENLAFAXINE XRAND SSRIS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN PRIMARY AND SECONDARY CARE IN SPAIN, Value in Health, November 2007, Elsevier, DOI: 10.1016/s1098-3015(10)65077-2.
You can read the full text:
The following have contributed to this page